Phase I-II Trial of Gemcitabine Plus Nab-paclitaxel (GemBrax) Followed by Folfirinox as First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Paclitaxel (Primary) ; Folinic acid; Gemcitabine; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions
- 02 Dec 2016 New trial record
- 11 Oct 2016 Results (n=33) asessing safety presented at the 41st European Society for Medical Oncology Congress.